Literature DB >> 15542094

Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries.

Ari Hörman1, Heikki Korpela, Jussi Sutinen, Hans Wedel, Marja-Liisa Hänninen.   

Abstract

We aimed to apply the meta-analysis in the studies of protozoan pathogens in order to obtain a general overview of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in asymptomatic and symptomatic human populations in the Nordic countries of Denmark, Finland, Norway and Sweden. In combining the data of 13 clinically and methodologically non-heterogeneous studies published before 2004 using the random effects model with DerSimonian-Laird estimator, we estimated the prevalence (% prevalence: 95% confidence limits) of Giardia cases in the asymptomatic (i.e. no gastroenteric symptoms) general population to be 2.97% (2.64; 3.31) and in the symptomatic population 5.81% (5.34; 6.30). For Cryptosporidium the prevalences were 0.99% (0.81; 1.19) and 2.91% (2.71; 3.12), respectively. In analyzing the data, we estimated that there will be 4670 (4300; 5060) symptomatic cases of Giardia and 3340 (3110; 3580) symptomatic cases of Cryptosporidium annually per 100,000 general population in the Nordic countries. The vast majority of cases will remain unregistered in the national registers of infectious diseases, since for single registered cases there will be 254-867 cases of Giardia undetected/unregistered and 4072 to 15,181 cases of Cryptosporidium, respectively.

Entities:  

Mesh:

Year:  2004        PMID: 15542094     DOI: 10.1016/j.ijpara.2004.08.009

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  25 in total

1.  Post epidemic giardiasis and gastrointestinal symptoms among preschool children in Bergen, Norway. A cross-sectional study.

Authors:  Kristin M Mellingen; Anita Midtun; Kurt Hanevik; Geir E Eide; Øystein Søbstad; Nina Langeland
Journal:  BMC Public Health       Date:  2010-03-26       Impact factor: 3.295

Review 2.  Zoonotic potential and molecular epidemiology of Giardia species and giardiasis.

Authors:  Yaoyu Feng; Lihua Xiao
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 3.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 4.  Cryptosporidium pathogenicity and virulence.

Authors:  Maha Bouzid; Paul R Hunter; Rachel M Chalmers; Kevin M Tyler
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

5.  Adhesive-tape recovery combined with molecular and microscopic testing for the detection of Cryptosporidium oocysts on experimentally contaminated fresh produce and a food preparation surface.

Authors:  Ronald Fayer; Monica Santin; Dumitru Macarisin; Gary Bauchan
Journal:  Parasitol Res       Date:  2013-02-15       Impact factor: 2.289

6.  A family outbreak of cryptosporidiosis: Probable nosocomial infection and person-to-person transmission.

Authors:  Nenad Pandak; Kristof Zeljka; Ante Cvitkovic
Journal:  Wien Klin Wochenschr       Date:  2006-08       Impact factor: 1.704

7.  Spinacia oleracea L. leaf stomata harboring Cryptosporidium parvum oocysts: a potential threat to food safety.

Authors:  Dumitru Macarisin; Gary Bauchan; Ronald Fayer
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

8.  Giardiasis in kindergartens: prevalence study in Berlin, Germany, 2006.

Authors:  D Sagebiel; T Weitzel; K Stark; K Leitmeyer
Journal:  Parasitol Res       Date:  2009-04-29       Impact factor: 2.289

Review 9.  Giardia and Cryptosporidium and public health: the epidemiological scenario from the Italian perspective.

Authors:  Annunziata Giangaspero; Federica Berrilli; Olga Brandonisio
Journal:  Parasitol Res       Date:  2007-06-26       Impact factor: 2.289

10.  Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after.

Authors:  Kristine Mørch; Kurt Hanevik; Guri Rortveit; Knut-Arne Wensaas; Geir Egil Eide; Trygve Hausken; Nina Langeland
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.